Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41

Franck Lemiale, Hedi Haddada, Gary J. Nabel, Douglas E. Brough, C. Richter King, Jason G D Gall

Research output: Contribution to journalArticle

Abstract

Replication-defective adenovirus vectors, primarily developed from serotype 5 (Ad5) viruses, have been widely used for gene transfer and vaccination approaches. Vectors based on other serotypes of adenovirus could be used in conjunction with, or in place of, Ad5 vectors. In this study, Ad41, an enteric adenovirus usually described as 'non-cultivable' or 'fastidious,' has been successfully cloned, rescued and propagated on 293-ORF6 cells. The complementation capabilities of this cell line allow generation of Ad41 vectors at titers comparable to those obtained for Ad5 vectors. Mice immunized with an Ad41 vector containing an HIV envelope (Env) gene mounted anti-Env cellular and humoral immune responses. Ad41-Env vectors appear to be particularly attractive when used in heterologous prime-boost regimens, where they induce significantly higher cellular immune responses to HIV-Env than Ad5-based regimens. Ad41-based constructs are attractive vaccine vectors alone or in combination with Ad5 adenovectors, since each vector type can provide circumvention of pre-existing immunity to the other.

Original languageEnglish (US)
Pages (from-to)2074-2084
Number of pages11
JournalVaccine
Volume25
Issue number11
DOIs
StatePublished - Mar 1 2007
Externally publishedYes

Fingerprint

Adenovirus Vaccines
vector vaccines
Adenoviridae
tropics
serotypes
Cellular Immunity
cell-mediated immunity
HIV
Humoral Immunity
gene transfer
humoral immunity
Genes
Immunity
Vaccination
Vaccines
immunity
vaccination
cell lines
Viruses
Cell Line

Keywords

  • Adenovirus
  • Human Immunodeficiency Virus
  • Vaccine vector

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Lemiale, F., Haddada, H., Nabel, G. J., Brough, D. E., King, C. R., & Gall, J. G. D. (2007). Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41. Vaccine, 25(11), 2074-2084. https://doi.org/10.1016/j.vaccine.2006.11.025

Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41. / Lemiale, Franck; Haddada, Hedi; Nabel, Gary J.; Brough, Douglas E.; King, C. Richter; Gall, Jason G D.

In: Vaccine, Vol. 25, No. 11, 01.03.2007, p. 2074-2084.

Research output: Contribution to journalArticle

Lemiale, F, Haddada, H, Nabel, GJ, Brough, DE, King, CR & Gall, JGD 2007, 'Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41', Vaccine, vol. 25, no. 11, pp. 2074-2084. https://doi.org/10.1016/j.vaccine.2006.11.025
Lemiale F, Haddada H, Nabel GJ, Brough DE, King CR, Gall JGD. Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41. Vaccine. 2007 Mar 1;25(11):2074-2084. https://doi.org/10.1016/j.vaccine.2006.11.025
Lemiale, Franck ; Haddada, Hedi ; Nabel, Gary J. ; Brough, Douglas E. ; King, C. Richter ; Gall, Jason G D. / Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41. In: Vaccine. 2007 ; Vol. 25, No. 11. pp. 2074-2084.
@article{f09e1aa24cc54c46a35273ec7f7b251a,
title = "Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41",
abstract = "Replication-defective adenovirus vectors, primarily developed from serotype 5 (Ad5) viruses, have been widely used for gene transfer and vaccination approaches. Vectors based on other serotypes of adenovirus could be used in conjunction with, or in place of, Ad5 vectors. In this study, Ad41, an enteric adenovirus usually described as 'non-cultivable' or 'fastidious,' has been successfully cloned, rescued and propagated on 293-ORF6 cells. The complementation capabilities of this cell line allow generation of Ad41 vectors at titers comparable to those obtained for Ad5 vectors. Mice immunized with an Ad41 vector containing an HIV envelope (Env) gene mounted anti-Env cellular and humoral immune responses. Ad41-Env vectors appear to be particularly attractive when used in heterologous prime-boost regimens, where they induce significantly higher cellular immune responses to HIV-Env than Ad5-based regimens. Ad41-based constructs are attractive vaccine vectors alone or in combination with Ad5 adenovectors, since each vector type can provide circumvention of pre-existing immunity to the other.",
keywords = "Adenovirus, Human Immunodeficiency Virus, Vaccine vector",
author = "Franck Lemiale and Hedi Haddada and Nabel, {Gary J.} and Brough, {Douglas E.} and King, {C. Richter} and Gall, {Jason G D}",
year = "2007",
month = "3",
day = "1",
doi = "10.1016/j.vaccine.2006.11.025",
language = "English (US)",
volume = "25",
pages = "2074--2084",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "11",

}

TY - JOUR

T1 - Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41

AU - Lemiale, Franck

AU - Haddada, Hedi

AU - Nabel, Gary J.

AU - Brough, Douglas E.

AU - King, C. Richter

AU - Gall, Jason G D

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Replication-defective adenovirus vectors, primarily developed from serotype 5 (Ad5) viruses, have been widely used for gene transfer and vaccination approaches. Vectors based on other serotypes of adenovirus could be used in conjunction with, or in place of, Ad5 vectors. In this study, Ad41, an enteric adenovirus usually described as 'non-cultivable' or 'fastidious,' has been successfully cloned, rescued and propagated on 293-ORF6 cells. The complementation capabilities of this cell line allow generation of Ad41 vectors at titers comparable to those obtained for Ad5 vectors. Mice immunized with an Ad41 vector containing an HIV envelope (Env) gene mounted anti-Env cellular and humoral immune responses. Ad41-Env vectors appear to be particularly attractive when used in heterologous prime-boost regimens, where they induce significantly higher cellular immune responses to HIV-Env than Ad5-based regimens. Ad41-based constructs are attractive vaccine vectors alone or in combination with Ad5 adenovectors, since each vector type can provide circumvention of pre-existing immunity to the other.

AB - Replication-defective adenovirus vectors, primarily developed from serotype 5 (Ad5) viruses, have been widely used for gene transfer and vaccination approaches. Vectors based on other serotypes of adenovirus could be used in conjunction with, or in place of, Ad5 vectors. In this study, Ad41, an enteric adenovirus usually described as 'non-cultivable' or 'fastidious,' has been successfully cloned, rescued and propagated on 293-ORF6 cells. The complementation capabilities of this cell line allow generation of Ad41 vectors at titers comparable to those obtained for Ad5 vectors. Mice immunized with an Ad41 vector containing an HIV envelope (Env) gene mounted anti-Env cellular and humoral immune responses. Ad41-Env vectors appear to be particularly attractive when used in heterologous prime-boost regimens, where they induce significantly higher cellular immune responses to HIV-Env than Ad5-based regimens. Ad41-based constructs are attractive vaccine vectors alone or in combination with Ad5 adenovectors, since each vector type can provide circumvention of pre-existing immunity to the other.

KW - Adenovirus

KW - Human Immunodeficiency Virus

KW - Vaccine vector

UR - http://www.scopus.com/inward/record.url?scp=33846857302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846857302&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2006.11.025

DO - 10.1016/j.vaccine.2006.11.025

M3 - Article

VL - 25

SP - 2074

EP - 2084

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 11

ER -